Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Yanagisawa, Kazuaki; Komoda, Fumio*
JAEA-Review 2010-003, 28 Pages, 2010/06
JAEA-Review-2010-003.pdf:0.94MB
By using the database INSPEC, an ex-post evaluation of the safety research was carried out by a technology interaction analysis. Selected institutions were JAERI, ORNL and FZK. As the control term of INSPEC a water-reactor-safety was utilized and studied the established key technologies and the interacted technological elements. (1) For a nuclear safety research JAERI held priority to 22 out of 30 key technologies consisted of the nuclear fuels, the nuclear materials and so on. JAERI contributed much to Japan. For ORNL and FZK, 19 and 20 key technologies were held priorities. ORNL was in the ascendant at the nuclear power plant operation, while FZK held priority to the radiation protection. (2) JAERI and FZK interacted strongly with the accident, the engineering calculation, the fuel cladding and the reactor core cooling. The interaction was enhanced by an international cooperation like LOFT. As for JAERI and ORNL, they interacted strongly with the instruments and the research reactors.
Komoda, Fumio*; Suzuki, Akiko*; Yanagisawa, Kazuaki; Inoue, Tomio*
Annals of Nuclear Medicine, 23(10), p.829 - 841, 2009/12
Times Cited Count：1 Percentile：7.52(Radiology, Nuclear Medicine & Medical Imaging)The number of newly approved medicines for market decreased because of the great disparity between animal model in pre-clinical trial and human model in clinical trial. This bottleneck may be expected to be gotten rid of by change in paradigm of drug development based on microdosing, which is enabled by radiation related imaging technology. However, this is impossible without being accompanied by interdisciplinary joint researches, in which clinical investigators belonging to medical schools or hospitals play the most decisive role. In this article, authors verify based on bibliometrics that Japan has not employed the opportunity for revitalizing drug research activities because Japanese researchers' attitude towards radiation technology may not be so positive in comparison with the US, and because the role which clinical investigators play in the phase of pre-clinical trial is smaller in Japan than in the U.S.A..
Yanagisawa, Kazuaki; Kume, Tamikazu*; Makuuchi, Keizo*; Inoue, Tomio*; Komoda, Fumio*; Maeda, Mitsuru*
Dekomisshoningu Giho, (39), p.44 - 61, 2009/03
A benefit born as an inheritance from disposed low level radioactive waste is considered. In the present study, a direct economic scale of application of radiation in Japanese industry, agriculture and medicine is taken as parameter for quantifying the size of benefit. In 2006, the economic scale is about 21 billion dollars for industry, 2.5 billion dollars for agriculture and 14 billion dollars for medicine. Economic scale covered the all fields is totaled 37 billion dollars. Due to those benefit, one can drive a car and play an internet, pleasure the dinning food. Diagnosis and treatment by nuclear medicine can possible to survive the millions of lives and resulting in improving the quality of life, decreasing pain and suffering. However, most Japanese (more than 80%) may not aware those benefits to date. This report is prepared for aiming at disseminating those benefits to our peoples.
Yanagisawa, Kazuaki; Komoda, Fumio*
no journal, ,
no abstracts in English
Yanagisawa, Kazuaki; Kume, Tamikazu; Makuuchi, Keizo*; Inoue, Tomio*; Komoda, Fumio*; Maeda, Mitsuru*
no journal, ,
Products produced by using radiological application (electron and 
ray etc.) at industrial and agricultural fields as well as reimbursement of medical and dental cares in Japanese market was studied at fiscal year 2006. This is to certify the quantitative role of radiological application, which will benefit the welfare of the people of our nation. The shipment of semiconductor has the largest share in our industrial market, having economic scale approximately of 4,800 billion yen. The net value taking into consideration of attributed ratio of radiation as much as 23% will be 1,082 billion yen. The shipment of rice born by mutation has the largest share in our agricultural market (90% of the total), having economic scale approximately of 260 billion yen. Application of radiation is done at medical and dentistry fields, an economic scale based on reimbursement is 1,620 billion yen.
